{"entity":{"type":"insider","cik":"0002064348","url":"/insider/0002064348","json_url":"/insider/0002064348.json","name":"Grant-Huerta Yanina","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":5,"first":"2025-05-20","last":"2026-05-20","span_basis":"filed_date"},"name_variants":[{"name":"Grant-Huerta Yanina","source":"filing","n_filings":5,"first_seen":"2025-05-20","last_seen":"2026-05-20"}],"transactions":[{"id":5768267,"accession":"0000905148-26-002570","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-26-002570","line_url":"/filing/0000905148-26-002570#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0002064348","owner_name":"Grant-Huerta Yanina","owner_display_name":"Grant-Huerta Yanina","owner_url":"/insider/0002064348","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2414.0,"shares_display":"2,414","price_per_share":9.1286,"price_display":"9.13","price_state":"stated","total_value":22036.4404,"total_display":"22,036.44","total_whole":"22,036","shares_owned_after":49636.0,"shares_owned_after_display":"49,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-20","scope":"insider"},{"id":5804942,"accession":"0000905148-26-001144","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000905148-26-001144","line_url":"/filing/0000905148-26-001144","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0002064348","owner_name":"Grant-Huerta Yanina","owner_display_name":"Grant-Huerta Yanina","owner_url":"/insider/0002064348","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2104.0,"shares_display":"2,104","price_per_share":5.0812286121673,"price_display":"5.08","price_state":"stated","total_value":10690.905,"total_display":"10,690.90","total_whole":"10,691","shares_owned_after":32227.0,"shares_owned_after_display":"32,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider","n_lines":4},{"id":4192424,"accession":"0000905148-25-004140","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-25-004140","line_url":"/filing/0000905148-25-004140","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0002064348","owner_name":"Grant-Huerta Yanina","owner_display_name":"Grant-Huerta Yanina","owner_url":"/insider/0002064348","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1804.0,"shares_display":"1,804","price_per_share":13.18629933481153,"price_display":"13.19","price_state":"stated","total_value":23788.084,"total_display":"23,788.08","total_whole":"23,788","shares_owned_after":33613.0,"shares_owned_after_display":"33,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-19","scope":"insider","n_lines":3},{"id":5149003,"accession":"0000905148-25-003069","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-25-003069","line_url":"/filing/0000905148-25-003069","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0002064348","owner_name":"Grant-Huerta Yanina","owner_display_name":"Grant-Huerta Yanina","owner_url":"/insider/0002064348","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1809.0,"shares_display":"1,809","price_per_share":11.613800442233279,"price_display":"11.61","price_state":"stated","total_value":21009.365,"total_display":"21,009.36","total_whole":"21,009","shares_owned_after":35258.0,"shares_owned_after_display":"35,258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-20","scope":"insider","n_lines":3},{"id":4043057,"accession":"0000905148-25-001866","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-25-001866","line_url":"/filing/0000905148-25-001866#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0002064348","owner_name":"Grant-Huerta Yanina","owner_display_name":"Grant-Huerta Yanina","owner_url":"/insider/0002064348","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2218.0,"shares_display":"2,218","price_per_share":6.763,"price_display":"6.76","price_state":"stated","total_value":15000.334,"total_display":"15,000.33","total_whole":"15,000","shares_owned_after":37067.0,"shares_owned_after_display":"37,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Officer (Chief Accounting Officer)","n_filings":5,"first_seen":"2025-05-20","last_seen":"2026-05-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002064348","retrieved_at":"2026-08-22T08:48:09+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}